John T. Curnutte

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Jennifer Woo, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John T. Curnutte:

Company Role Class Num Shares Value Price $ Report Date Ownership
PLIANT THERAPEUTICS, INC. Director Common Stock (Right to Buy) 30,000 $55,669 $2.08 05 Jun 2025 Direct
Orchard Therapeutics plc Director Stock Option (Right to Buy) 0 24 Jan 2024 Direct

Insider Reports Filed by John T. Curnutte

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PLRX PLIANT THERAPEUTICS, INC. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 20:44
PLRX PLIANT THERAPEUTICS, INC. 13 Jun 2024 1 $0 4 Director 17 Jun 2024, 20:15
/report/000095017024007052-curnutte-john-t-2024-01-24 Orchard Therapeutics plc 24 Jan 2024 2 $0 4 Director 24 Jan 2024, 17:16
/report/000120919123037906-curnutte-john-t-2023-06-14 Orchard Therapeutics plc 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:30
PLRX PLIANT THERAPEUTICS, INC. 07 Jun 2023 1 $0 4 Director 08 Jun 2023, 17:14
PLRX PLIANT THERAPEUTICS, INC. 16 Jun 2022 1 $0 4 Director 21 Jun 2022, 16:18
/report/000120919122035006-curnutte-john-t-2022-06-07 Orchard Therapeutics plc 07 Jun 2022 1 $0 4 Director 08 Jun 2022, 16:05
PLRX PLIANT THERAPEUTICS, INC. 29 Jun 2021 1 $0 4 Director 30 Jun 2021, 20:24
/report/000120919121041499-curnutte-john-t-2021-06-16 Orchard Therapeutics plc 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 17:01